Fate Therapeutics Inc
Open
SectorHealthcare
2 -11.11
Overview
Share price change
24h
Min
2.05
Max
2.29
Income | 1.2M -31M |
|---|---|
Sales | -70K 1.3M |
EPS | -0.26 |
Profit margin | -2,402.848 |
Employees | 161 |
EBITDA | 14M -28M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +154.37% upside |
Next Earnings | 10 sie 2026 |
|---|
Market Cap | -2.9M 251M |
|---|---|
Previous open | 13.11 |
Previous close | 2 |
News Sentiment
By Acuity
50%
50%
146 / 342 Ranking in Healthcare
Fate Therapeutics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Fate Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 5.24 USD 154.37%
High 8 USD
Low 2.2 USD
Based on 9 Wall Street analysts offering 12 month price targets forFate Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$